The goal of the FABHALTA is to mitigate the occurrence and morbidity associated with encapsulated bacterial infections (Neisseria meningitidis and Streptococcus pneumoniae) by educating healthcare providers and patients. Iptacopan is a Factor B inhibitor of the alternative complement pathway, indicated for the treatment of adults with paroxysmal nocturnal hemoglobinuria (PNH).
DNS
View domain name system records, including the A, AAAA, MX and NS records.